Clinical Trials Browser

Carcinoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06969833 2026-03-17

BCB-OVAIRE

Phase NA Recruiting

371 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06184867 2026-03-06

CATALYST

Phase NA Completed

50 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07362147 2026-01-23

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

Phase NA Not yet recruiting

74 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases, Vaginal Neoplasms, Endometrial Neoplasms

NCT06466382 2026-01-12

OVPrecision

Phase NA Recruiting

60 enrolled

Gynecologic

Fallopian Tube Neoplasms

NCT04204811 2026-01-07

Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

Phase NA Active not recruiting

22 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06855706 2026-01-06

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Phase NA Recruiting

120 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05220033 2025-12-30

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

Phase NA Active not recruiting

30 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT06710548 2025-12-17

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Phase NA Recruiting

240 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05236686 2025-11-19

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Phase NA Recruiting

94 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Lymphatic Metastasis, Ovarian Neoplasms

NCT05287451 2025-11-05

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Phase NA Recruiting

100 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06451263 2025-09-19

Nudge to Gynecologic Oncology

Phase NA Active not recruiting

20 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05047926 2025-08-08

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Phase NA Completed

90 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02470299 2025-05-22

Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

Phase NA Completed

21 enrolled

Gynecologic

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT05429970 2025-05-18

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Phase NA Recruiting

35 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Clinical Trials

TILsOV

BCB-OVAIRE

CATALYST

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

OVPrecision

Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study

Nudge to Gynecologic Oncology

Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)